IMMUNITYBIO INC (IBRX) Institutional Shareholders

IMMUNITYBIO INC (IBRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.75B in IBRX holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of IBRX tracked by InsiderSet, reporting ownership valued at approximately $298.40M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $269.60M, representing an estimated loss of -9.65% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed IBRX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., State Street Corp, Vanguard Portfolio Management Llc, and several other long-term asset managers with concentrated positions in IMMUNITYBIO INC (IBRX).

This page ranks the largest institutional IBRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

385

Total Reported Value

$1.75B

Largest Holder

Blackrock, Inc.

Largest Position

$298.40M

Insider Transactions (90d)

13

Latest Filing Quarter

Q2 2026

New Institutional Positions

50

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%34,083,262$298,398,958$269,598,602-$28,800,356-9.65%
State Street Corp0.01%21,398,438$187,343,325$169,261,645-$18,081,680-9.65%
Vanguard Portfolio Management Llc0.01%17,863,911$156,398,541$141,303,536-$15,095,005-9.65%
Vanguard Capital Management Llc0.00%15,691,579$137,379,774$124,120,390-$13,259,384-9.65%
D. E. Shaw & Co., Inc.0.06%11,551,019$101,129,171$91,368,560-$9,760,611-9.65%
Two Sigma Investments, Lp0.07%11,097,106$97,155,163$87,778,108-$9,377,055-9.65%
Geode Capital Management, Llc0.00%9,847,896$86,230,624$77,896,857-$8,333,767-9.66%
Millennium Management Llc0.03%5,579,793$48,851,088$44,136,163-$4,714,925-9.65%
Northern Trust Corp0.00%3,565,248$31,213,746$28,201,112-$3,012,634-9.65%
Morgan Stanley0.00%3,432,678$30,053,096$27,152,483-$2,900,613-9.65%
Goldman Sachs Group Inc0.00%3,234,277$28,316,099$25,583,131-$2,732,968-9.65%
Ubs Group Ag0.00%3,195,728$27,978,598$25,278,208-$2,700,390-9.65%
Charles Schwab Investment Management Inc0.00%2,888,607$25,289,754$22,848,881-$2,440,873-9.65%
Woodline Partners Lp0.07%2,500,189$21,889,155$19,776,495-$2,112,660-9.65%
Seb Asset Management Ab0.08%2,447,150$21,424,757$19,356,957-$2,067,801-9.65%
Vanguard Fiduciary Trust Co0.00%2,412,338$21,120,019$19,081,594-$2,038,425-9.65%
Bank Of America Corp0.00%2,184,489$19,125,201$17,279,308-$1,845,893-9.65%
Voloridge Investment Management, Llc0.06%1,721,902$15,075,252$13,620,245-$1,455,007-9.65%
Federated Hermes, Inc.0.02%1,713,200$14,999,066$13,551,412-$1,447,654-9.65%
Royal Bank Of Canada0.00%1,542,717$13,506,000$12,202,891-$1,303,109-9.65%
Jpmorgan Chase & Co0.00%1,450,180$12,871,781$11,470,924-$1,400,857-10.88%
Vestor Capital, Llc0.76%44,835$12,054,000$354,645-$11,699,355-97.06%
Bank Of New York Mellon Corp0.00%1,314,760$11,510,727$10,399,752-$1,110,975-9.65%
First Trust Advisors Lp0.01%1,214,667$10,634,409$9,608,016-$1,026,393-9.65%
Cetera Investment Advisers0.01%1,140,476$9,984,867$9,021,165-$963,702-9.65%
Renaissance Technologies LLCJim Simons0.01%1,029,399$9,012,388$8,142,546-$869,842-9.65%
Lpl Financial Llc0.00%1,021,057$8,939,354$8,076,561-$862,793-9.65%
Osaic Holdings, Inc.0.01%875,621$7,670,411$6,926,162-$744,249-9.70%
Nuveen, Llc0.00%859,612$7,525,903$6,799,531-$726,372-9.65%
Pictet Asset Management Holding Sa0.01%847,659$7,433,121$6,704,983-$728,138-9.80%
Squarepoint Ops Llc0.01%760,993$6,662,494$6,019,455-$643,039-9.65%
Wells Fargo & Company/Mn0.00%737,031$6,452,703$5,829,915-$622,788-9.65%
Barclays Plc0.00%730,336$6,394,093$5,776,958-$617,135-9.65%
Swiss National Bank0.00%722,000$6,321,110$5,711,020-$610,090-9.65%
Clearwater Capital Advisors, Llc0.46%717,524$6,281,923$5,675,615-$606,308-9.65%
Trexquant Investment Lp0.04%696,547$6,098,269$5,509,687-$588,582-9.65%
Allen Holding Inc0.59%687,571$6,019,684$5,438,687-$580,997-9.65%
Kercheville Advisors, Llc1.72%644,685$5,644,219$5,099,458-$544,761-9.65%
Citigroup Inc0.00%550,276$4,817,667$4,352,683-$464,984-9.65%
Voleon Capital Management Lp0.09%549,126$4,807,598$4,343,587-$464,011-9.65%
D.A. Davidson & Co.0.03%538,924$4,718,279$4,262,889-$455,390-9.65%
Sheets Smith Wealth Management0.45%512,572$4,487,568$4,054,445-$433,123-9.65%
Centerbook Partners Lp0.21%495,942$4,341,972$3,922,901-$419,071-9.65%
Deutsche Bank Ag\0.00%487,571$4,271,122$3,856,687-$414,435-9.70%
Rhumbline Advisers0.00%476,935$4,175,557$3,772,556-$403,001-9.65%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%532,675$4,085,618$4,213,459+$127,841+3.13%
Alliancebernstein L.P.0.00%527,460$4,045,618$4,172,209+$126,591+3.13%
Voya Investment Management Llc0.00%451,125$3,949,599$3,568,399-$381,200-9.65%
Legacy Capital Group California, Inc.1.18%446,000$3,904,730$3,527,860-$376,870-9.65%
Price T Rowe Associates Inc0.00%441,444$3,865,000$3,491,822-$373,178-9.66%
Showing 50 of 385

Frequently asked questions about IBRX

  • Who owns the most IBRX stock?

    The largest holders of IBRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for IMMUNITYBIO INC (IBRX).

  • Is IBRX widely held by superinvestors?

    Many widely followed stocks like IBRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly IBRX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.